QINGYUN REN,SIEGFRIED GOLDMANN,YINGJUN ZHANG,XINCHANG LIU,CHAOLEI WANG,TIANMING WANG
申请号：
PT13841041
公开号：
PT2900664T
申请日:
2013.09.27
申请国别(地区):
PT
年份:
2018
代理人:
摘要：
The present invention relates to crystalline forms of dihydropyrimidine derivatives, and pharmaceutical compositions comprising the crystalline forms disclosed herein, which may be used for preventing, managing, treating or lessening the severity of a viral disease in a patient, especially hepatitis B infection or a disease caused by hepatitis B infection.
